Baxter Aktiengesellschaft
Records under this name other than patents Baxter Aktiengesellschaft holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Back to Baxter Aktiengesellschaft
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,703,426 | Composition Exhibiting a von Willebrand Factor (vWF) Protease Activity Comprising a Polypeptide Chain with the Amino Acid Sequence AAGGILHLELLV Formerly held Term ended Ended no later than Feb 7, 2023 · Low confidence | Term ended | Ended no later than Feb 7, 2023 | Low confidence |
| US 9,504,778 | Dialysis Machine with Electrical Insulation for Variable Voltage Input Term ended Term ended Nov 19, 2022 · High confidence | Term ended | Term ended Nov 19, 2022 | High confidence |
| US 7,033,590 | Factor IX/factor IXa activating antibodies and antibody derivatives Formerly held Term ended Term ended Dec 20, 2021 · From the USPTO record | Term ended | Term ended Dec 20, 2021 | From the USPTO record |
| US 6,958,322 | Factor X analog with an improved ability to be activated Formerly held Term ended Term ended Sep 3, 2021 · From the USPTO record | Term ended | Term ended Sep 3, 2021 | From the USPTO record |
| US 6,974,792 | Alpha 1-Antitrypsin Preparation as Well as a Method for Producing the Same Formerly held Term ended Term ended Jun 10, 2021 · Medium confidence | Term ended | Term ended Jun 10, 2021 | Medium confidence |
| US 6,926,894 | Composition Exhibiting a Von Willebrand Factor (VWF) Protease Activity Comprising a Polypeptide Chain with the Amino Acid Sequence Aaggilhlellv Formerly held Term ended Term ended May 13, 2021 · Medium confidence | Term ended | Term ended May 13, 2021 | Medium confidence |
| US 8,709,492 | Process for producing a plasma protein-containing medicament with reduced concentration of citrate and metals Formerly held Term ended Term ended May 4, 2021 · Medium confidence | Term ended | Term ended May 4, 2021 | Medium confidence |
| US 7,241,603 | Method for Producing a Preparation Based on Fibrinogen and Fibronectin as Well as Protein Compositions Obtainable According to This Method Formerly held Term ended Term ended Dec 1, 2020 · Medium confidence | Term ended | Term ended Dec 1, 2020 | Medium confidence |
| US 7,501,117 | Composition Exhibiting a Von Willebrand Factor (VWF) Protease Activity Comprising a Polypeptide Chain with the Amino Acid Sequence Aaggilhlellv Formerly held Term ended Term ended Nov 22, 2020 · Low confidence | Term ended | Term ended Nov 22, 2020 | Low confidence |
| US 6,506,365 | Fibrin/fibrinogen binding conjugate Formerly held Term ended Term ended Sep 25, 2020 · From the USPTO record | Term ended | Term ended Sep 25, 2020 | From the USPTO record |